The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Researchers from the CLÍNIC-IDIBAPS, the Hospital Universitari Vall d’Hebron and the Parc Taulí de Sabadell have shown the damage caused by the SARS-1
Interview with Dr. Manel Juan, head of the Immunology Service
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1
In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the wor1
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Ho1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1
